Literature DB >> 22059350

Diminished absolute counts of CD56dim and CD56bright natural killer cells in peripheral blood from Egyptian patients with hepatocellular carcinoma.

Amal Fathy1, Mohamed Mohy Eldin, Lobna Metwally, Mohamed Eida, Marwa Abdel-Rehim.   

Abstract

Natural killer cells (NK) as components of the innate immunity substantially contribute to anti-tumor immune responses, NK cell subpopulations can be defined on the basis of the relative expression of CD16 and CD56 markers. Earlier research demonstrated a dramatic reduction in the frequency of peripheral blood CD56dimCD16+ NK subsets in hepatocellular carcinoma (HCC) patients compared with healthy subjects. We aim to assess the relative and absolute counts of natural killer cells subsets in hepatitis C-related HCC among Egyptian patients. Flowcytometric analysis of peripheral blood NK subsets was performed for HCV with HCC patients (n=20) and HCV without HCC patients (n=14) as compared to healthy control subjects (n=152). We found that HCC patients displayed a marked reduction in the relative frequency of peripheral CD56im subsets compared with healthy subjects. Moreover, there was a significant reduction in the absolute counts of CD56dim16+, CD56dim16- and CD56bright. In conclusion, this study demonstrated that the absolute counts of dim and bright NK cell subsets were decreased in different proportions in patients with HCV-related HCC that refers to a possible role for these cells, particularly CD 56 bright cells, in the immune response to HCC. This might aid in developing new therapeutic strategies targeting both NK subsets for HCC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 22059350

Source DB:  PubMed          Journal:  Egypt J Immunol


  11 in total

Review 1.  Natural Killer Cells and Type 1 Innate Lymphoid Cells in Hepatocellular Carcinoma: Current Knowledge and Future Perspectives.

Authors:  Nicolas Jacquelot; Cyril Seillet; Fernando Souza-Fonseca-Guimaraes; Adrian G Sacher; Gabrielle T Belz; Pamela S Ohashi
Journal:  Int J Mol Sci       Date:  2021-08-22       Impact factor: 5.923

2.  Sorafenib may enhance antitumour efficacy in hepatocellular carcinoma patients by modulating the proportions and functions of natural killer cells.

Authors:  Jie Hu; Enxin Wang; Lei Liu; Qiuhe Wang; Dongdong Xia; Wei Bai; Jun Tie; Xiaomei Li; Jie Yuan; Shuya Yang; Dongbo Jiang; Jingqi Shi; Yuanjie Sun; Jing Wang; Chunmei Zhang; Jing Niu; Kai Li; Chuangye He; Wengang Guo; Yong Lv; Hui Chen; Xulong Yuan; Tianlei Yu; Zhengyu Wang; Bohan Luo; Na Han; Ying Zhu; Zhanxin Yin; Daiming Fan; Zhuoli Zhang; Kun Yang; Guohong Han
Journal:  Invest New Drugs       Date:  2019-12-13       Impact factor: 3.850

Review 3.  NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma.

Authors:  Cheng Sun; Haoyu Sun; Cai Zhang; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2014-10-13       Impact factor: 11.530

Review 4.  Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy.

Authors:  Cheng Sun; Hao-yu Sun; Wei-hua Xiao; Cai Zhang; Zhi-gang Tian
Journal:  Acta Pharmacol Sin       Date:  2015-06-15       Impact factor: 6.150

Review 5.  Combinational immune-cell therapy of natural killer cells and sorafenib for advanced hepatocellular carcinoma: a review.

Authors:  Faezeh Hosseinzadeh; Javad Verdi; Jafar Ai; Saieh Hajighasemlou; Iman Seyhoun; Frzad Parvizpour; Fatemeh Hosseinzadeh; Abolfazl Iranikhah; Sadegh Shirian
Journal:  Cancer Cell Int       Date:  2018-09-10       Impact factor: 5.722

Review 6.  Hepatic Natural Killer Cells: Organ-Specific Sentinels of Liver Immune Homeostasis and Physiopathology.

Authors:  Joanna Mikulak; Elena Bruni; Ferdinando Oriolo; Clara Di Vito; Domenico Mavilio
Journal:  Front Immunol       Date:  2019-04-30       Impact factor: 7.561

Review 7.  Signaling Pathways Tuning Innate Lymphoid Cell Response to Hepatocellular Carcinoma.

Authors:  Elsa Bourayou; Rachel Golub
Journal:  Front Immunol       Date:  2022-02-23       Impact factor: 7.561

Review 8.  Natural Killer Cells in Liver Disease and Hepatocellular Carcinoma and the NK Cell-Based Immunotherapy.

Authors:  Pingyi Liu; Lingling Chen; Haiyan Zhang
Journal:  J Immunol Res       Date:  2018-09-04       Impact factor: 4.818

Review 9.  Tumor microenvironment in primary liver tumors: A challenging role of natural killer cells.

Authors:  Michela Anna Polidoro; Joanna Mikulak; Valentina Cazzetta; Ana Lleo; Domenico Mavilio; Guido Torzilli; Matteo Donadon
Journal:  World J Gastroenterol       Date:  2020-09-07       Impact factor: 5.742

Review 10.  Natural Killer-Dendritic Cell Interactions in Liver Cancer: Implications for Immunotherapy.

Authors:  Valentina Cazzetta; Sara Franzese; Claudia Carenza; Silvia Della Bella; Joanna Mikulak; Domenico Mavilio
Journal:  Cancers (Basel)       Date:  2021-05-01       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.